READY TO GO
Live / Registered — Registered and renewed (as of 15 Oct 2021)
What this means for you
Registered since 05 Jun 2001. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Jun 2021).
Record
- Serial number
- 75522569
- Registration number
- 2456617
- Mark type
- Word mark
- Filed
- 20 Jul 1998
- Published for opposition
- 13 Mar 2001
- Registered
- 05 Jun 2001
- Next maintenance due
- 05 Jun 2021
- Attorney of record
- Dyan M. House
Goods and services
- Class 001 — Chemicals: [Pre-mixed, pre-dispensed dispensed reagents], regeants, namely, nucleotides and nucleotide preparations, ionic salts, buffer, and stabilizing reagents, or a combination thereof, for performing; polymerase chain reaction, DNA profiling experiments and random amplified polymorphic DNA analysis detection, labeling and or sequencing of DNA; pre-mixed, pre-dispensed reagents, [namely, a lambda packaging kits primarily comprised of nucleotides and nucleotide preparations for in vitro packaging and planting of CDNA and biochemicals namely, sets of cloned DNA fragments that together represent the entire genome, to the genes transcribed by a particular tissue cloned into bacteriophage lambda DNA; pre-mixed, pre-dispensed reagents,] namely, vectors for the general cloning, sequencing and expression of foreign genes; pre-mixed, pre-dispensed reagents,[, namely, polynucleotide kinase for use in the detection labeling and or sequencing of DNA or RNA and chemical reagents for use therewith;] and pre-mixed, pre-dispensed reagents, namely, DNA ligase for covalently joining DNA fragments; all for scientific and research use
- Class 005 — Pharmaceuticals: [PRE-MIXED, PRE-DISPENSED REAGENTS, namely, NUCLEOTIDES AND NUCLEOTIDE PREPARATIONS, IONIC SALTS, BUFFER, AND STABILIZING REAGENTS, OR A COMBINATION THEREOF, FOR PERFORMING, POLYMERASE CHAIN REACTION, DNA PROFILING EXPERIMENTS AND RANDOM AMPLIFIED POLYMORPHIC DNA ANALYSIS DETECTION, LABELING AND OR SEQUENCING OF DNA; PRE-MIXED, PRE-DISPENSED REAGENTS, namely, A LAMBDA PACKAGING KIT PRIMARILY COMPRISED OF NUCLEOTIDES AND NUCLEOTIDE PREPARATIONS FOR IN VITRO PACKAGING AND PLANTING OF CDNA AND BIOCHEMICALS NAMELY, SETS OF CLONED DNA FRAGMENTS THAT TOGETHER REPRESENT THE ENTIRE GENOME, TO THE GENES TRANSCRIBED BY A PARTICULAR TISSUE CLONED INTO BACTERIOPHAGE LAMBDA DNA; PRE-MIXED, PRE-DISPENSED REAGENTS, namely, VECTORS FOR THE GENERAL CLONING, SEQUENCING AND EXPRESSION OF FOREIGN GENES; PRE-MIXED, PRE-DISPENSED REAGENTS, namely, POLYNUCLEOTIDE KINASE FOR USE IN THE DETECTION LABELING AND OR SEQUENCING OF DNA OR RNA AND CHEMICAL REAGENTS FOR USE THEREWITH; AND PRE-MIXED, PRE-DISPENSED REAGENTS, NAMELY, DNA LIGASE FOR COVALENTLY JOINING DNA FRAGMENTS; ALL FOR MEDICAL OR CLINICAL LABORATORY USE]
Owner
- CYTIVA SWEDEN AB, UPPSALA, SE
- GE HEALTHCARE BIO-SCIENCES AB, UPPSALA, SE
- GE HEALTHCARE BIOPROCESS R&D AB, UPPSALA, SE
- GE HEALTHCARE BIO-SCIENCES AB, Uppsala, SE
- Amersham Pharmacia Biotech Inc., Piscataway, NJ, US
- Amersham Pharmacia Biotech Inc., Piscataway, NJ, US
- Amersham Pharmacia Biotech Inc., Piscataway, NJ, US
Prior registrations
Prosecution history
- 19 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Oct 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 19 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Oct 2021 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 15 Oct 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL